Overexpression of the E2F1 and its impact on cancer progression have recently been associated with miRNA deregulation in different types of cancer: melanoma, lung cancer, glioma and CRC, where marked reduction in expression was observed for MIR205, MIR493, MIR329 and MIR362, respectively [25–28]. This evidence concerns the gene E2F1 and central nervous system cancer.